Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis
Recruiting
University of Athens
Phase 4
2014-05-30
Psoriasis has been associated with an increasing risk for atherosclerosis. The investigators
investigated whether surrogate markers of subclinical atherosclerosis, vascular dysfunction
and myocardial dysfunction are impaired in patients with psoriasis compared to normal
controls ,coronary artery disease patients and untreated hypertension subjects. The
investigators also examined the effect of treatment with biological vs no biological agents
on vascular and LV function in psoriasis.
Immunologic Response to Secukinumab in Plaque Psoriasis
Completed
Novartis Pharmaceuticals
Phase 4
2016-10-01
This is a single-arm, open-label study, which will examine the effect of secukinumab on the
immunologic and genetic environment within psoriatic lesions.
Immunologic Response to Secukinumab in Plaque Psoriasis
Completed
University of California, San Francisco
Phase 4
2016-10-01
This is a single-arm, open-label study, which will examine the effect of secukinumab on the
immunologic and genetic environment within psoriatic lesions.
Anti-IL-17 a New Treatment for Contact Dermatititis
Unknown status
Tanja Todberg, MD
Phase 3
2016-01-01
The purpose of this study is to assess the efficacy of anti-IL 17 treatment (secukinumab) in
patients with known severe allergic contact dermatitis (ACD).
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
